Effect of nutrient restriction on the somatotropes and substance P-immunoreactive cells in the pituitary of the female ovine fetus

Growth Hormone and IGF Research

Volumn 16, Issue 2, 2006, Pages 108-118

  Lutz, Lacey ^a   Dufourny, Laurence ^b   Skinner, Donal C ^a  

^a UNIVERSITY OF WYOMING   (United States)

^b UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

Author keywords

Growth hormone; Programming; Somatotropes; Substance P; Tachykinin; Undernutrition

Indexed keywords

GROWTH HORMONE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL SIZE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FETUS; FETUS DEVELOPMENT; GESTATION PERIOD; GROWTH HORMONE SECRETING CELL; HYPOPHYSIS; HYPOPHYSIS CELL; IMMUNOCYTOCHEMISTRY; MALNUTRITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEEP; STATISTICAL SIGNIFICANCE;

ANIMALS; FEMALE; FETAL DEVELOPMENT; FOOD DEPRIVATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH HORMONE; MATERNAL-FETAL EXCHANGE; PITUITARY GLAND; PREGNANCY; SHEEP; SUBSTANCE P;

EID: 33747168482     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.02.003     Document Type: Article

References (78)

1. Kuh D., and Smith G.D. When is mortality risk determined? Historical insights into a current debate. Soc. Hist. Med. 6 (1993) 101-123
2. Lucas A. Role of nutritional programming in determining adult morbidity. Arch. Dis. Child 71 (1994) 288-290
3. Fowden A.L., and Forhead A.J. Endocrine mechanisms of intrauterine programming. Reproduction 127 (2004) 515-526
4. Brodsky D., and Christou H. Current concepts in intrauterine growth restriction. J. Intensive Care Med. 19 (2004) 307-319
5. Hoet J.J., and Hanson M.A. Intrauterine nutrition: its importance during critical periods for cardiovascular and endocrine development. J. Physiol. 514 Pt 3 (1999) 617-627
6. Oliver M.H., Bloomfield F.H., Harding J.E., Breier B.H., Bassett N.S., and Gluckman P.D. The maternal, fetal and postnatal somatotrophic axes in intrauterine growth retardation. Biochem. Soc. Trans. 27 (1999) 69-73
7. Barker D.J. Fetal programming of coronary heart disease. Trends Endocrinol. Metab. 13 (2002) 364-368
8. Edwards L.J., and McMillen I.C. Impact of maternal undernutrition during the periconceptional period, fetal number, and fetal sex on the development of the hypothalamo-pituitary adrenal axis in sheep during late gestation. Biol. Reprod. 66 (2002) 1562-1569
9. Holt R.I.G. Fetal programming of the growth hormone-insulin-like growth factor axis. Trends Endocrinol. Metab. 13 (2002) 392-397
10. Gluckman P.D., and Pinal C.S. Regulation of fetal growth by the somatotrophic axis. J. Nutr. 133 (2003) 1741-S1746
11. Zadik Z. Maternal nutrition, fetal weight, body composition and disease in later life. J. Endocrinol. Invest. 26 (2003) 941-945
12. Gluckman P.D., and Harding J.E. Fetal growth retardation: underlying endocrine mechanisms and postnatal consequences. Acta Paediatr. 422 Suppl. (1997) 69-72
13. Giustina A., and Veldhuis J.D. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 19 (1998) 717-797
14. Muller E.E., Locatelli V., and Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol. Rev. 79 (1999) 511-607
15. Bauer M.K., Breier B.B., Bloomfield F.H., Jensen E.C., Gluckman P.D., and Harding J.E. Chronic pulsatile infusion of growth hormone to growth-restricted fetal sheep increases circulating fetal insulin-like growth factor-I levels but not fetal growth. J. Endocrinol. 177 (2003) 83-92
16. Jost A. Anterior pituitary function in foetal life. In: Harris G.D. (Ed). The Pituitary Gland vol. 3 (1966), University of California Press, Berkeley 299-323
17. Osgerby J.C., Wathes D.C., Howard D., and Gadd T.S. The effect of maternal undernutrition on ovine fetal growth. J. Endocrinol. 173 (2002) 131-141
18. Bauer M.K., Breier B.H., Harding J.E., Veldhuis J.D., and Gluckman P.D. The fetal somatotropic axis during long term maternal undernutrition in sheep: evidence for nutritional regulation in utero. Endocrinology 136 (1995) 1250-1257
19. Boersma B., and Wit J.M. Catch-up growth. Endocr. Rev. 18 (1997) 646-661
20. Boguszewski M., Bjarnason R., Jansson C., Rosberg S., and Albertsson-Wikland K. Hormonal status of short children born small for gestational age. Acta Paediatr. 423 Suppl. (1997) 189-192
21. Woods K.A., van Helvoirt M., Ong K.K., Mohn A., Levy J., de Zegher F., et al. The somatotropic axis in short children born small for gestational age: relation to insulin resistance. Pediatr. Res. 51 (2002) 76-80
22. Bassett J.M., and Madill D. The influence of maternal nutrition on plasma hormone and metabolite concentrations of foetal lambs. J. Endocrinol. 61 (1974) 465-477
23. Koritnik D.R., Humphrey W.D., Kaltenbach C.C., and Dunn T.G. Effects of maternal undernutrition on the development of the ovine fetus and the associated changes in growth hormone and prolactin. Biol. Reprod. 24 (1981) 125-137
24. Schaefer A.L., Krishnamurti C.R., Heindze A.M., and Gopinath R. Effect of maternal starvation on fetal tissue nucleic acid, plasma amino acid and growth hormone concentration in sheep. Growth 48 (1984) 404-414
25. Debeljuk L., Wright J.C., Phelps C., and Bartke A. Transgenic mice overexpressing the growth-hormone-releasing hormone gene have high concentrations of tachykinins in the anterior pituitary gland. Neuroendocrinology 70 (1999) 107-116
26. Houben H., and Denef C. Unexpected effects of peptide and nonpeptide substance P receptor antagonists on basal prolactin and growth hormone release in vitro. Peptides 14 (1993) 109-115
27. Vonnahme K.A., Hess B.W., Hansen T.R., McCormick R.J., Rule D.C., Moss G.E., et al. Maternal undernutrition from early- to mid-gestation leads to growth retardation, cardiac ventricular hypertrophy, and increased liver weight in the fetal sheep. Biol. Reprod. 69 (2003) 133-140
28. Skinner D.C., and Dufourny L. Oestrogen receptor β-immunoreactive neurones in the ovine hypothalamus: distribution and colocalisation with gonadotropin-releasing hormone. J. Neuroendocrinol. 17 (2005) 29-39
29. Mignot M., and Skinner D.C. Colocalization of GH, TSH and prolactin, but not ACTH, with βLH-immunoreactivity: evidence for pluripotential cells in the ovine pituitary. Cell Tissue Res. 319 (2005) 413-421
30. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 94 (1946) 239-247
31. Jaffe C.A., Huffman B.W., and Demott-Friberg R. Insulin hypoglycemia and growth hormone secretion in sheep: a paradox revisited. Am. J. Physiol. 277 (1999) E253-E258
32. Dong F., Ford S.P., Fang C.X., Nijland M.J., Nathanielsz P.W., and Ren J. Maternal nutrient restriction during early to mid gestation up-regulates cardiac insulin-like growth factor (IGF) receptors associated with enlarged ventricular size in fetal sheep. Growth Horm. IGF Res. 15 (2005) 291-299
33. Ho K.Y., Veldhuis J.D., Johnson M.L., Furlanetto R., Evans W.S., Alberti K.G., et al. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J. Clin. Invest. 81 (1988) 968-975
34. Childs G.V. Development of gonadotropes may involve cyclic transdifferentiation of growth hormone cells. Arch. Physiol. Biochem. 110 (2002) 42-49
35. Bloomfield F.H., Oliver M.H., Giannoulias D.C., Gluckman P.D., Harding J.E., and Challis J.R. Brief undernutrition in late-gestation sheep programmes the HPA axis in adult offspring. Endocrinology 144 (2003) 1-30
36. Osgerby J.C., Wathes D.C., Howard D., and Gadd T.S. The effect of maternal undernutrition on the placental growth trajectory and the uterine insulin-like growth factor axis in the pregnant ewe. J. Endocrinol. 182 (2004) 89-103
37. Gallaher B.W., Breier B.H., Keven C.L., Harding J.E., and Gluckman P.D. Fetal programming of insulin-like growth factor (IGF)-I and IGF-binding protein-3: evidence for an altered response to undernutrition in late gestation following exposure to periconceptual undernutrition in the sheep. J. Endocrinol. 159 (1998) 501-508
38. Huizinga C.T., Oudejans C.B., and Delemarre-van de Waal H.A. Persistent changes in somatostatin and neuropeptide Y mRNA levels but not in growth hormone-releasing hormone mRNA levels in adult rats after intrauterine growth retardation. J. Endocrinol. 168 (2001) 273-281
39. Phillips L.S. Nutrition, somatomedins, and the brain. Metabolism 35 (1986) 78-87
40. Nilson J.H., Fink P.A., Virgin J.B., Cserbak M.T., Camper S.A., and Rottman F.M. Developmental expression of growth hormone and prolactin genes in the bovine pituitary. J. Biol. Chem. 258 (1983) 4565-4570
41. Stahl J.H., Kendall S.K., Brinkmeier M.L., Greco T.L., Watkins-Chow D.E., Campos-Barros A., et al. Thyroid hormone is essential for pituitary somatotropes and lactotropes. Endocrinology 140 (1999) 1884-1892
42. Scanes C.G., Proudman J.A., and Radecki S.V. Influence of continuous growth hormone or insulin-like growth factor I administration in adult female chickens. Gen. Comp. Endocrinol. 114 (1999) 315-323
43. Dean C.E., and Porter T.E. Regulation of somatotroph differentiation and growth hormone (GH) secretion by corticosterone and GH-releasing hormone during embryonic development. Endocrinology 140 (1999) 1104-1110
44. Driver P.M., and Forbes J.M. Episodic growth hormone secretion in sheep in relation to time of feeding, spontaneous meals and short term fasting. J. Physiol. 317 (1981) 413-424
45. Renaville R., Hammadi M., and Portetelle D. Role of the somatotropic axis in the mammalian metabolism. Domest. Anim. Endocrinol. 23 (2002) 351-360
46. Scacchi M., Ida Pincelli A., and Cavagnini F. Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa. Front Neuroendocrinol. 24 (2003) 200-224
47. Levy A. Physiological implications of pituitary trophic activity. J. Endocrinol. 174 (2002) 147-155
48. Nolan L.A., Thomas C.K., and Levy A. Pituitary mitosis and apoptotic responsiveness following adrenalectomy are independent of hypothalamic paraventricular nucleus CRH input. J. Endocrinol. 181 (2004) 521-529
49. Tortoriello D.V. The plastic fetal pituitary. J. Clin. Invest. 110 (2002) 749-750
50. Butler T.G., Schwartz J., and McMillen I.C. Differential effects of the early and late intrauterine environment on corticotrophic cell development. J. Clin. Invest. 110 (2002) 783-791
51. Villalobos C., Nunez L., and Garcia-Sancho J. Anterior pituitary thyrotropes are multifunctional cells. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E1166-E1170
52. Villalobos C., Nunez L., and Garcia-Sancho J. Phenotypic characterization of multi-functional somatotropes, mammotropes and gonadotropes of the mouse anterior pituitary. Pflugers Arch. 449 (2004) 257-264
53. Bassett N.S., and Gluckman P.D. Pulsatile growth hormone secretion in the ovine fetus and neonatal lamb. J. Endocrinol. 109 (1986) 307-312
54. de Zegher F., Daaboul J., Grumbach M.M., and Kaplan S.L. Hormone ontogeny in the ovine fetus and neonate. XXII. The effect of somatostatin on the growth hormone (GH) response to GH-releasing factor. Endocrinology 124 (1989) 1114-1117
55. Gluckman P.D., Mueller P.L., Kaplan S.L., Rudolph A.M., and Grumbach M.M. Hormone ontogeny in the ovine fetus. I. Circulating growth hormone in mid and late gestation. Endocrinology 104 (1979) 162-168
56. Polkowska J. Development of the gonadotrophic and somatotrophic axes of sheep. J. Reprod. Fertil. Suppl. 49 (1995) 187-195
57. Zeitler P., Tannenbaum G.S., Clifton D.K., and Steiner R.A. Ultradian oscillations in somatostatin and growth hormone-releasing hormone mRNAs in the brains of adult male rats. Proc. Natl. Acad. Sci. USA 88 (1991) 8920-8924
58. Blanchard M.M., Goodyer C.G., Charrier J., and Barenton B. In vitro regulation of growth hormone (GH) release from ovine pituitary cells during fetal and neonatal development: effects of GH-releasing factor, somatostatin, and insulin-like growth factor I. Endocrinology 122 (1988) 2114-2120
59. Goodyer C.G., Branchaud C.L., and Lefebvre Y. Effects of growth hormone (GH)-releasing factor and somatostatin on GH secretion from early to midgestation human fetal pituitaries. J. Clin. Endocrinol. Metab. 76 (1993) 1259-1264
60. Kineman R.D., Teixeira L.T., Amargo G.V., Coschigano K.T., Kopchick J.J., and Frohman L.A. The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling. Endocrinology 142 (2001) 3764-3773
61. Frohman L.A., and Jansson J.O. Growth hormone-releasing hormone. Endocr. Rev. 7 (1986)
62. Lin-Su K., and Wajnrajch M.P. Growth hormone-releasing hormone (GHRH) and the GHRH receptor. Rev. Endocr. Metab. Disord. 3 (2002) 313-323
63. Mayo K.E., Miller T., DeAlmeida V., Godfrey P., Zheng J., and Cunha S.R. Regulation of the pituitary somatotroph cell by GHRH and its receptor. Recent. Prog. Horm. Res. 55 (2000) 237-266
64. Miller T.L., Godfrey P.A., DeAlmeida V.I., and Mayo K.E. The rat growth hormone-releasing hormone receptor gene: structure, regulation, and generation of receptor isoforms with different signaling properties. Endocrinology 140 (1999) 4152-4165
65. Debeljuk L., Steger R.W., Wright J.C., Mattison J., and Bartke A. Effects of overexpression of growth hormone-releasing hormone on the hypothalamo-pituitary-gonadal function in the mouse. Endocrine 11 (1999) 171-179
66. Frohman L.A., and Kineman R.D. Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis. Trends Endocrinol. Metab. 13 (2002) 299-303
67. Frohman L.A., Kineman R.D., Kamegai J., Park S., Teixeira L.T., Coschigano K.T., et al. Secretagogues and the somatotrope: signaling and proliferation. Recent Prog. Horm. Res. 55 (2000) 269-290
68. Frohman L.A., and Kineman R.D. Growth hormone-releasing hormone and pituitary somatotrope proliferation. Minerva. Endocrinol. 27 (2002) 277-285
69. Brown E.R., Roth K.A., and Krause J.E. Sexually dimorphic distribution of substance P in specific anterior pituitary cell populations. Proc. Natl. Acad. Sci. USA 88 (1991) 1222-1226
70. Morel G., Chayvialle J.A., Kerdelhue B., and Dubois P.M. Ultrastructural evidence for endogenous substance-P-like immunoreactivity in the rat pituitary gland. Neuroendocrinology 35 (1982) 86-92
71. Roth K.A., and Krause J.E. Substance-P is present in a subset of thyrotrophs in the human pituitary. J. Clin. Endocrinol. Metab. 71 (1990) 1089-1095
72. Bohlooly Y.M., Bollano E., Mobini R., Soussi B., Tornell J., and Omerovic E. Selective cerebral overexpression of growth hormone alters cardiac function, morphology, energy metabolism and catecholamines in transgenic mice. Growth Horm. IGF Res. 15 (2005) 148-155
73. Lipshultz S.E., Vlach S.A., Lipsitz S.R., Sallan S.E., Schwartz M.L., and Colan S.D. Cardiac changes associated with growth hormone therapy among children treated with anthracyclines. Pediatrics 115 (2005) 1613-1622
74. Lu C., Schwartzbauer G., Sperling M.A., Devaskar S.U., Thamotharan S., Robbins P.D., et al. Demonstration of direct effects of growth hormone on neonatal cardiomyocytes. J. Biol. Chem. 276 (2001) 22892-22900
75. Miyague N.I., and Ghidini A. Effect of fetal growth restriction on ultrasonographically measured cardiac size. Early Hum. Dev. 48 (1997) 93-98
76. Bartke A., Chandrashekar V., Turyn D., Steger R.W., Debeljuk L., Winters T.A., et al. Effects of growth hormone overexpression and growth hormone resistance on neuroendocrine and reproductive functions in transgenic and knock-out mice. Proc. Soc. Exp. Biol. Med. 222 (1999) 113-123
77. Chandrashekar V., Zaczek D., and Bartke A. The consequences of altered somatotropic system on reproduction. Biol. Reprod. 71 (2004) 17-27
78. Mondal M., and Prakash B.S. Effects of long-term GH-releasing factor administration on patterns of GH and LH secretion in growing female buffaloes (Bubalus bubalis). Reproduction 127 (2004) 45-55